ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

1.200 -0.010 (-0.83%)

Streaming Delayed Price Updated: 1:42 PM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,711,152
Open	1.220
Bid (Size)	1.200 (16,300)
Ask (Size)	1.210 (6,100)
Prev. Close	1.210
Today's Range	1.160 - 1.220
52wk Range	0.8227 - 4.079
Shares Outstanding	174,537,458
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near ↗

June 04, 2026

Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a...

Via MarketBeat

Akebia (AKBA) Q1 2026 Earnings Transcript ↗

May 08, 2026

Akebia (AKBA) Q1 2026 Earnings Transcript

Via The Motley Fool

Performance

YTD	-22.6%	-22.6%
1 Month	+17.6%	+17.6%
3 Month	-14.9%	-14.9%
6 Month	-25.5%	-25.5%
1 Year	-66.4%	-66.4%

More News

Akebia (AKBA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

An Overview of Akebia Therapeutics's Earnings ↗

November 07, 2025

Via Benzinga

AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗

February 26, 2026

Via Stocktwits

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M ↗

December 01, 2025

Via Stocktwits

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 04, 2025

Via Benzinga

Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗

October 29, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Preview For Akebia Therapeutics ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Insights Ahead: Akebia Therapeutics's Quarterly Earnings ↗

May 07, 2025

Via Benzinga

FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug ↗

October 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket ↗

October 29, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

October 28, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 28, 2025

Via Benzinga

Akebia (AKBA) Q2 Revenue Jumps 43% ↗

August 07, 2025

Via The Motley Fool

9 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 08, 2025

Via Benzinga

Frequently Asked Questions

Is Akebia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?

Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?

The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market

What is the current price of Akebia Therapeutics, Inc. - Common Stock?

The current price of Akebia Therapeutics, Inc. - Common Stock is 1.200

When was Akebia Therapeutics, Inc. - Common Stock last traded?

The last trade of Akebia Therapeutics, Inc. - Common Stock was at 07/02/26 01:42 PM ET

What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?

The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 209.44M

How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?

Akebia Therapeutics, Inc. - Common Stock has 209M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.